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Purpose: To characterize the clinical phenotype, histopathological features, and molecular genetic basis of an Avellino
corneal dystrophy (ACD) in a Chinese family.
Methods: A complete ophthalmologic examination was performed in 21 individuals (6 affected and 15 unaffected) of the
four-generation family. DNA was obtained from peripheral blood leukocytes of each participant. Genetic analysis included
TGFBI polymerase chain reaction (PCR) amplification and automated nucleotidic sequenceing of all 17 exons of genomic
DNA. Histological analysis of corneal tissue from the proband was performed after a penetrating keratoplasty. One hundred
Chinese controls were scanned for the presence of the R124H mutation by amplifying TGFBI exon 4 and then by direct
sequencing of PCR products.
Results: The proband of the pedigree had phenotypic features consistent with diagnosis of ACD. He was homozygous
for the same R124H mutation in TGFBI as previously reported in Japan and European countries. In addition, 4 affected
and 7 unaffected individuals carried the same variation in the heterozygous state were identified. None of the 100 control
subjects was positive for this mutation. Moreover, a variable expressivity and an apparent non-penetrance were observed
in the individuals with heterozygous R124H mutation in our pedigree. After excluding the missed diagnosis or a late onset,
it could be interpreted as a reduced penetrance.
Conclusions: We reported a novel ACD family which exhibited a reduced penetrance of phenotype in northern China.
This outcome supports that although the R124H mutation is one of the genetic causes of the disease, different genetic and
environmental factors may influence the expressivity and the penetrance. Uncovering the mechanism may facilitate us to
inhibit the occurrence of the corneal dystrophy caused by the R124H mutation in TGFBI, irrespective of the homozygous
and heterozygous mutation.
Corneal  dystrophies  (CDs)  are  hereditary  diseases
involving  the  formation  of  corneal  opacities  on  different
layers of the cornea, which lead to significant impairment of
corneal transparency and refraction [1]. In 1997, Munier et al.
[2] identified the gene on chromosome 5q31 responsible for
these autosomal dominant corneal dystrophies: transforming
growth factor beta-induced (TGFBI, OMIM 601692, formerly
called  BIGH3).  Four  separate  mutations  were  discovered,
resulting  in  four  distinct  corneal  dystrophies  including
granular dystrophy (GCD; R555W), lattice dystrophy type I
(LCD-I;  R124C),  Avellino  dystrophy  (ACD;  R124H)  and
Reis-Bücklers dystrophy (RBCD; R555Q).
ACD  (also  known  as  GCD-II)  is  one  of  the  TGFBI
associated corneal dystrophies, of which the clinical aspect is
the  coexistence  of  granular  deposits  and  histological
amyloidal  deposits  in  the  cornea  [3].  The  name  of  the
dystrophy comes from Avellino, Italy – a city where three
families  affected  with  the  disease  originated  [4].  It  is
characterized clinically by corneal opacities that are shaped
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like  rings,  disks,  stars,  and  snowflakes.  Early  clinical
symptoms of ACD appear during the first or second decade
of life. Linear opacities may be present [5,6], but the typical
lines of LCD are usually absent. Compared to GCD-I, the
progression of ACD is delayed and slower and the visual
acuity is less impaired. In the absence of a histopathologic
evaluation or a examination of the molecular genetic defect,
ACD can be difficult to be distinguished from GCD-I. In
Japanese individuals, ACD is the most common hereditary
corneal dystrophy, responsible for 72% of corneal dystrophies
associated with TGFBI [7]. The cause of this unique spectrum
is not clear.
To date, all ACD cases studied with molecular genetic
technique have demonstrated a mutation in codon 124 of
TGFBI in which histidine replaces arginine (R124H) [8-11].
The disease is more severe in homozygous patients than in
their  heterozygous  counterparts  [10,11].  In  this  study,  we
report a novel family of ACD with the same mutation that
exhibited  a  reduced  penetrance  of  phenotype  in  northern
China.
METHODS
Patients: A four-generation ACD family was collected from
the  Heilongjiang  province  in  northern  China  (Figure  1).
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70Informed  consent  which  adhered  to  the  Declaration  of
Helsinki and the Heilongjiang Institutional Review Board was
obtained from all participants. Twenty-one members of the
family were enrolled, 6 affected and 15 unaffected. The ages
ranged from 2 to 74 years. All the members (except IV1) were
examined  over  3  years.  One  hundred  unrelated  healthy
volunteers were recruited as controls.
Clinical evaluation: The affected status of all participating
members  was  determined  by  extensive  ophthalmologic
examinations, which included best corrected visual acuity
test, slit-lamp examination, corneal thickness measurement,
intraocular  pressure  measurement,  and  dilated  fundus
examination. Detailed clinical histories were obtained and
particular attention was paid to the age of onset, initial signs
and  symptoms,  progression  of  disease,  and  other  ocular
therapeutic procedures. The corneal phenotypes of affected
individuals were documented by slit-lamp photography and
assessed  by  at  least  two  investigators  ignorant  of  the
genotypes.
Molecular analysis: Peripheral blood was collected from each
of the 6 affected and 15 unaffected family members, and
genomic DNA was extracted using a QIAamp DNA Blood
Mini Kit (Qiagen, Hilden, Germany). All 17 exons of TGFBI
were  analyzed  by  the  polymerase  chain  reaction  (PCR)
amplification and DNA sequencing. The forward and reverse
primers and the PCR conditions we used were as described by
Afshari et al. [12] and Munier et al. [2,13]. The PCR products
were purified with a QIAquick PCR Purification Kit (Qiagen,
Valencia, CA) and sequenced on both strands using the ABI
BigDye Terminator Cycle Sequencing kit v3.1, (ABI Applied
Biosystems,  Foster  City,  CA).  Sequence  results  were
compared  with  the  wild  type  TGFBI  sequence  (GenBank
AY149344). The one hundred Chinese controls were scanned
for the presence of the R124H mutation by amplifying the
exon 4 and then by direct sequencing of PCR products.
Histologic evaluation: Corneal tissue obtained at penetrating
keratoplasty was available from the proband for histologic
study. Tissue sections were examined by light microscopy
after being stained with hematoxylin-eosin (H&E), Masson’s
trichrome, periodic acid Schiff (PAS), and Congo red.
RESULTS
Clinical findings: Clinical features of family members are
summarized  in  Table  1.  The  age  at  onset  for  affected
individuals was between 9 and 28, with a mean of 18.7–19.3
years. At onset, symptoms related to either visual loss or
foreign body sensation, both of which were usually bilateral
at that stage. The progress of corneal opacities in affected
members was commonly symmetric.
The proband (II4) was a 43-year-old man who was the
offspring of a consanguineous marriage. He was 11 years old
when he had bilateral foreign body sensation and a visual
defect. He had experienced progressive deterioration in visual
acuity  bilateral  over  the  preceding  32  years.  Corneal
examination revealed grayish spot-like confluent opacities
presented in the anterior stroma and covered almost the entire
cornea (Figure 2A). Ultimately, penetrating keratoplasty was
performed on his right eye at the age of 43. Visual acuity was
20 cm/CF in both eyes before the operation.
Figure 1. Pedigree showing a four-generation family affected by ACD. Circles represent females, squares represent males. The arrow indicates
the proband, and the filled symbols indicate affected individuals. Asterisks indicate members of the family who underwent clinical examination
and molecular analyses.
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about 24–28 years old and began with a mild foreign body
sensation. His visual acuity was 1.0 in both eyes when he was
74 years old. Slit-lamp examination showed several distinct
granular deposits in superficial stroma of the central cornea
(Figure 2B).
The earliest symptoms for III2 and III5 was foreign body
sensation  as  well.  The  ages  of  onset  were  22  and  25,
respectively. Multiple granular deposits and a few confluent
opacities  were  observed  in  the  anterior  stroma  of  central
cornea (Figure 2C,D). No visual defect was complained about.
Molecular genetic analysis: After direct sequencing of TGFBI
exons,  a  homozygous  sequence  variation  was  detected  at
nucleotide position c.371G>A in II3 and II4 (Figure 3B).The
variation lies in exon 4 and results in a arginine to histidine
acid substitution at the protein level (R124H). In addition, 4
affected (I1, II5, III2, and III5) and 7 unaffected (II1, II6, III6,
III7, III9, III10, and III11)family members carrying the same
variation  in  the  heterozygous  state  were  identified(Figure
TABLE 1. CLINICAL FEATURES IN FAMILY MEMBERS WITH THE TGFB1 R124H MUTATION.
Individual
     case                 Gender Age Status
TGFBI
 genotype onset
Symptoms
at onset
Visual acuity at presentation
OD OS
I1 M 74 Affected wt/R124H 24–28 FBS 1.0 1.0
II1 F 56 Unaffected wt/R124H - - 1.0 1.2
II3 F 49 Affected R124H/ R124H 9 VA↓FBS. Ph 10cm/CF 10cm/CF
II4 M 43 Affected R124H/ R124H 11 VA↓FBS. Ph 20cm/CF 20cm/CF
II5 F 41 Affected wt/R124H 21 VA↓FBS 0.8 0.8
II6 F 37 Unaffected wt/R124H - - 1.0 1.0
III2 F 29 Affected wt/R124H 22 FBS 1.0 1.0
III5 F 27 Affected wt/R124H 25 FBS 1.0 1.0
III6 F 23 Unaffected wt/R124H - - 1.0 1.0
III7 F 21 Unaffected wt/R124H - - 0.8 1.0
III9 F 13 Unaffected wt/R124H - - 1.0 1.0
III10 F 4 Unaffected wt/R124H - - 1.0 1.0
III11 F 11 Unaffected wt/R124H - - 1.0 1.0
M: male, F: female, OD: right eye, OS: left eye, wt: wild type, wt/R124H: heterozygous R124H mutation, R124H/R124H:
homozygous  R124H mutation, VA↓: visual acuity decreased, FBS: foreign body sensation, Ph: photophobia, CF: count finger.
Information that is not provided about clinically unaffected individuals is marked with a dash (-).
Figure  2.  Corneal  phenotype  of  the
affected family members with ACD due
to  an  R124H  mutation  in  TGFBI.  A:
Preoperative photograph of the right eye
of  proband  revealed  grayish  spot-like
confluent  opacities  presented  in  the
anterior stroma and covering almost the
entire cornea. B: Corneal examination
of  the  left  eye  of  I1  (father  of  the
proband)  showed  several  distinct
granular  deposits  in  the  superficial
stroma of the central cornea (arrows). C
and D: Multiple granular deposits and a
few confluent opacities were observed
in the anterior stroma of central cornea
in  both  right  eyes  of  III2  and  III5,
respectively.
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Age at3C) . None of the 100 control subjects was positive for this
mutation.
Histologic  evaluation:  A  corneal  button  that  was  excised
during a penetrating keratoplasty from the right eye of the
proband demonstrated variably sized and irregularly shaped
deposits  within  the  corneal  stroma.  These  deposits  were
situated mostly in the anterior and middle stroma and were
adjacent  to  Bowman's  membrane.  The  deposits  stained
positively with congo red in the anterior and middle stroma
indicating be amyloid (Figure 4A) and staining with Masson’s
trichrome showed bright red accumulation of hyaline under
Bowman's membrane (Figure 4B). In addition, the epithelium
showed focal areas of dehiscence from Bowman's membrane
(Figure 4B).
DISCUSSION
In this study, we found an ACD family which exhibited a
reduced  penetrance  of  phenotype  in  northern  China.  As
reported, ACD does not show complete dominance, and the
homozygotes  of  R124H  mutation  display  a  more  severe
phenotype than the heterozygotes do [10,11]. In our family,
the patients with the homozygous R124H mutation presented
an early onset, severe corneal opacities and visual acuity had
been impaired since childhood while the patients with the
heterozygous  mutation  showed  a  late  onset,  mild  corneal
deposits  and  nearly  no  complaint  about  visual  acuity.  In
Figure 3. Sequence analysis of TGFBI exon 4 in this family. A: A
normal sequence is shown, which encodes arginine in codon 124.
B: The proband had homozygous substitutions at nucleotide position
c.371G>A, which results in a arginine to histidine acid substitution
(R124H). C: The proband’s father had a heterozygous mutation of
R124H at the same position.
addition,  the  expressivity  among  these  heterozygotes  was
variable and it had no correlation with the age of patients. The
father of the proband (I1)was mildly affected at 74 years of
age. Moreover, we also found two individuals (II1,II6) who
carried the same heterozygous R124H mutation presented no
change to their corneal transparency and visual acuity at the
age of 56 and 37, respectively. The 29-year-old daughter of
II1  had  initial  symptoms  at  22  and  showed  phenotypic
characteristics  corresponding  to  ACD.  To  avoid  a  missed
diagnosis, the corneal status of all 7 unaffected (II1, II6, III6,
III7,  III9,  III10,  and  III11)  members  who  carried  the
heterozygous  mutation  were  assessed  by  at  least  two
investigators ignorant of the genotype. TGFBI exon 4 of these
individuals was sequenced on both strands and repeated three
times. The absence of disease in individual II1 most likely
represents non-penetrance, rather than a missed diagnosis or
a  later  onset  of  disease.  At  this  point  of  view,  our  study
observed a unique family of ACD which presented a reduced
penetrance. This has not been previously reported in the study
of ACD.
To date almost all cases studied with molecular genetic
techniques for ACD have had the R124H mutation in TGFBI
but the phenotype of affected individuals varies markedly in
severity from family to family [10,14-17]. Watanabe et al.
[18] observed two different clinical phenotypes of ACD in
Japanese patients homozygous for the R124H mutation. In
one  variant  a  discrete  grayish  white  opacity  covered  the
anterior  stroma  and  it  was  confluent  in  the  central  and
paracentral cornea. In the other type, a reticular grayish white
diffuse opacity was found in the anterior stroma of the cornea.
Patients with the type II opacity traced their origin to Tottori
prefecture in western Japan. They considered that even though
the mutation in the gene responsible for the disease was the
same, other genes and factors could modify the phenotype of
the  corneal  opacity.  In  our  family,  patients  with  the
homozygous  TGFBI  R124H  mutation  presented  a  similar
phenotype to the type I from the Watanabe et al. [18] study.
Moreover, a markedly variabile expressivity and apparent
non-penetrance  were  observed  in  the  individuals  with
heterozygous  TGFBI  R124H  mutation  in  our  pedigree.  It
indicated that there might be some modified genes or factors
which could influence the phenotype of the causative gene.
It has been proven that modifier genes could play an
important role in phenotypic variability in other monogenic
disorders [19]. However, the genetic interactions between
modifier genes and the mutated genes in corneal dystrophies
is  unclear.  Watanabe  et  al.  [18]  explained  the  variable
phenotype in patients with the homozygous TGFBI R124H
mutation  in  their  family  for  three  possibilities.  They
considered that the trans acting genetic element, the cis acting
genetic element, and environmental factors may affect the
phenotype of the cornea with the homozygous TGFBI R124H
mutation. In our case, the reduced penetrance of phenotype
might be explained in the following ways. One possible reason
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parent. This gene could ameliorate the effect of the mutated
allele. Since such a protective gene could be absent in the
offspring, it can not exhibit any protective effect in these
individuals.  Another  explanation  may  be  the  loss  of  a
modified gene from the affected parent, which could worsen
the effect of the mutated allele. The final way is that the
environment may affect the penetrance of mutated genes. But,
our  explanation  about  the  genetic  basis  needs  further
determination. If those factors or genes could be identified, it
may be possible to delay or inhibit the disease occurrence.
In summary, we reported a novel ACD family which
exhibited  a  reduced  penetrance  of  phenotype  in  northern
China. The causative mutation was R124H in TGFBI. This
outcome supports that although the R124H mutation is one of
the  genetic  causes  of  the  disease,  different  genetic  and
environmental factors may influence the expressivity and the
penetrance. Uncovering the mechanism may lead to a way to
inhibit the occurrence of the corneal dystrophy caused by
R124H mutation in TGFBI, irrespective of the homozygous
and heterozygous mutation.
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